10.09
Mirum Pharmaceuticals pushes rare-disease strategy at Cantor healthcare conference
Mirum Pharmaceuticals used the Cantor Global Healthcare Conference to set out its rare-disease growth plans, with its liver and paediatric portfolios at the centre of the pitch to investors.